A molecular profile of T-cell exhaustion in cancer

Daniel E Speiser1

  • 1Ludwig Center and Radiation Oncology; University of Lausanne; Lausanne, Switzerland.

Oncoimmunology
|June 28, 2012
PubMed

Insights

Cancer-specific CD8+ T-cells show dysfunction due to molecular changes, similar to chronic infections. This T-cell exhaustion is reversible and localized to disease sites, suggesting new drug targets.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • CD8+ T-cells are crucial for anti-cancer immunity.
  • T-cell exhaustion is a known phenomenon in chronic infections, characterized by impaired function.
  • Understanding T-cell dysfunction in the tumor microenvironment is critical for improving cancer therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying CD8+ T-cell dysfunction in cancer.
  • To compare the gene expression profiles of cancer-infiltrating CD8+ T-cells with those in chronic infections.
  • To identify potential therapeutic targets for reversing T-cell exhaustion in cancer.

Main Methods:

  • Gene expression profiling of cancer-specific CD8+ T-cells.
  • Comparative analysis with T-cells from chronic infection models.
  • Analysis of molecular alterations associated with lymphocyte dysfunction.

Main Results:

  • The study is the first gene profiling of cancer-specific CD8+ T-cells.
  • Lymphocyte dysfunction in cancer tissue arises from multiple molecular alterations.
  • These alterations resemble those found in "exhausted" T-cells during chronic infections.

Conclusions:

  • T-cell exhaustion in cancer shares molecular similarities with chronic infections.
  • The identified molecular alterations suggest novel therapeutic targets for cancer treatment.
  • T-cell exhaustion is a reversible state and is anatomically restricted to disease sites.